Literature DB >> 27315305

Erratum to: Amorolfine 5% Nail Lacquer Exhibits Potent Antifungal Activity Compared to Three Acid-Based Devices Indicated for the Treatment of Onychomycosis: An In Vitro Nail Penetration Assay.

Mahmoud Ghannoum1, Karine Sevin2, Marlis Sarkany3.   

Abstract

Entities:  

Year:  2016        PMID: 27315305      PMCID: PMC4972730          DOI: 10.1007/s13555-016-0124-7

Source DB:  PubMed          Journal:  Dermatol Ther (Heidelb)


× No keyword cloud information.

Erratum to: Dermatol Ther (Heidelb) (2016) 6:69–75 DOI 10.1007/s13555-016-0093-x

In the original publication, in the Methods section, Scholl Fungal Nail Treatment is incorrectly attributed to Bayer Healthcare AG who is neither the manufacturer nor the market authorization holder. This should state Scholl Fungal Nail Treatment, Reckitt Benckiser Healthcare, UK.
  1 in total

1.  Daily Application of an Aqueous, Acidifying, Peelable Nail Polish versus Weekly Amorolfine for Topical Onychomycosis Treatment: A Prospective, Randomized, Blinded Trial.

Authors:  Frank Eertmans; Nejib Doss; Bart Rossel; Els Adriaens
Journal:  Dermatol Ther (Heidelb)       Date:  2018-07-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.